Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link. Yesterday, Feb. 24, 2014, 153 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $614.00 to $8,867,579,754,879.72.
Highlighted Stocks Traded by Insiders:
Ruckus Wireless (RKUS) - FREE Research Report Goetz James J who is Director at Ruckus Wireless sold 16,300 shares at $13.83 on Feb. 24, 2014. Following this transaction, the Director owned 41,029 shares meaning that the stake was reduced by 28.43% with the 16,300-share transaction.
The shares most recently traded at $13.81, down $0.02, or 0.14% since the insider transaction. Historical insider transactions for Ruckus Wireless go as follows:
- 4-Week # shares sold: 29,000
- 12-Week # shares sold: 193,617
- 24-Week # shares sold: 453,617
The average volume for Ruckus Wireless has been 1.1 million shares per day over the past 30 days. Ruckus Wireless has a market cap of $1.1 billion and is part of the technology sector and computer hardware industry. Shares are up 0.21% year-to-date as of the close of trading on Monday.
Ruckus Wireless, Inc. provides carrier-class Wi-Fi solutions to service providers and enterprises worldwide. Its products comprise gateways, controllers, and access points. The company has a P/E ratio of 77.1. Currently there are 8 analysts that rate Ruckus Wireless a buy, no analysts rate it a sell, and 4 rate it a hold.
Exclusive Offer: Get the latest Stock Analysis on RKUS - FREE TheStreet Quant Ratings rates Ruckus Wireless as a
sell. The company's weaknesses can be seen in multiple areas, such as its generally disappointing historical performance in the stock itself, deteriorating net income, premium valuation and feeble growth in its earnings per share. Get the full
Ruckus Wireless Ratings Report from
TheStreet Quant Ratings now.
STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.
Power Integrations (POWI) - FREE Research Report Nayyar Sandeep who is Chief Financial Officer at Power Integrations sold 3,408 shares at $60.25 on Feb. 24, 2014. Following this transaction, the Chief Financial Officer owned 33,018 shares meaning that the stake was reduced by 9.36% with the 3,408-share transaction.
The shares most recently traded at $59.03, down $1.22, or 2.07% since the insider transaction. Historical insider transactions for Power Integrations go as follows:
- 4-Week # shares sold: 36,505
- 12-Week # shares sold: 48,479
- 24-Week # shares sold: 54,581
The average volume for Power Integrations has been 220,200 shares per day over the past 30 days. Power Integrations has a market cap of $1.8 billion and is part of the technology sector and electronics industry. Shares are up 6.75% year-to-date as of the close of trading on Monday.
Power Integrations, Inc. designs, develops, manufactures, and markets analog and mixed-signal integrated circuits (ICs), and other electronic components and circuitry used in high-voltage power conversion. The stock currently has a dividend yield of 0.68%. The company has a P/E ratio of 31.5. Currently there are 4 analysts that rate Power Integrations a buy, no analysts rate it a sell, and 3 rate it a hold.
Exclusive Offer: Get the latest Stock Analysis on POWI - FREE TheStreet Quant Ratings rates Power Integrations as a
buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, solid stock price performance, impressive record of earnings per share growth and compelling growth in net income. We feel these strengths outweigh the fact that the company is trading at a premium valuation based on our review of its current price compared to such things as earnings and book value. Get the full
Power Integrations Ratings Report from
TheStreet Quant Ratings now.
STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.
Seattle Genetics (SGEN) - FREE Research Report Drachman Jonathan G who is Cmo & Evp, R & D at Seattle Genetics sold 1,241 shares at $53.25 on Feb. 24, 2014. Following this transaction, the Cmo & Evp, R & D owned 48,670 shares meaning that the stake was reduced by 2.49% with the 1,241-share transaction.
The shares most recently traded at $53.84, up $0.59, or 1.1% since the insider transaction. Historical insider transactions for Seattle Genetics go as follows:
- 4-Week # shares sold: 89,946
- 12-Week # shares sold: 147,157
- 24-Week # shares sold: 149,157
The average volume for Seattle Genetics has been 953,100 shares per day over the past 30 days. Seattle Genetics has a market cap of $6.7 billion and is part of the health care sector and drugs industry. Shares are up 36.2% year-to-date as of the close of trading on Monday.
Seattle Genetics, Inc., a biotechnology company, focuses on the development and commercialization of monoclonal antibody-based therapies for cancer. Its product candidate, ADCETRIS, has accelerated approval form the U.S. Currently there are 3 analysts that rate Seattle Genetics a buy, 2 analysts rate it a sell, and 4 rate it a hold.
Exclusive Offer: Get the latest Stock Analysis on SGEN - FREE TheStreet Quant Ratings rates Seattle Genetics as a
sell. The company's weaknesses can be seen in multiple areas, such as its feeble growth in its earnings per share, deteriorating net income and disappointing return on equity. Get the full
Seattle Genetics Ratings Report from
TheStreet Quant Ratings now.
STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.
